Researchers and business leaders unveil their plan for HGP-write to synthesize full genomes.
A proposal published in Science lays out a vision to drive down the cost of fabricating genomes and accelerate research and innovation in synthetic biology.
At a user meeting in London this week, Chief Technology Officer Clive Brown introduced the SmidgIon and a number of other technology developments, as well as a new synthetic biology spinoff.
Harvard's George Church says that a project to create synthetic human genomes at the center of last week's controversial meeting is at the 'thought experiment' stage.
Twist said it will use Genome Compiler's technology and expertise to build a portfolio of digital products, including a suite of gene design products.
Researchers have developed a programming language to design computational circuits for living cells.
The Cambridge, Massachusetts-based DNA manufacturer is looking to max out its production capacity, which works best at high volume and throughput.
Craig Venter and his colleagues develop a minimal bacterial genome of 473 genes, though the function of a third of those genes is unknown.
Synthetic biology may open up a number of manufacturing possibilities, but there are still obstacles to overcome, according to Nature News.
The deal is the latest partnership to provide exposure for Cambridge, Massachusetts-based Gen9's BioFab gene synthesis platform.
The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.
The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.
News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.
In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.